STICKNEY DWIGHT 4
4 · HOLLIS EDEN PHARMACEUTICALS INC /DE/ · Filed Oct 23, 2003
Insider Transaction Report
Form 4
STICKNEY DWIGHT
Chief Medical Officer
Transactions
- Purchase
Common Stock
2003-10-22$18.54/sh+2,285.745$42,378→ 2,285.745 total(indirect: By 401(k)) - Sale
Common Stock
2003-10-17$17.51/sh−2,266.865$39,688→ 0 total(indirect: By 401(k))
Holdings
- 1,000
Common Stock
Footnotes (1)
- [F1]Between July 1, 2003, and August 21, 2003, the reporting person acquired 2266.8645 shares of the Issuer's common stock under the Hollis-Eden Pharmaceuticals, Inc. 401(k) plan. The information in this report is based on a plan statement dated as of September 9, 2003.